Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Alnylam Pharmaceuticals, Inc. (NQ: ALNY)
28.98 USD  +0.92 (+3.28%)
Streaming Delayed Price  /  Updated: 4:00 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Alnylam Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
UPDATE: Deutsche Bank Initiates Coverage on Alnylam Pharmaceuticals with Buy Rating, $40 PT on Significant Long-Term Value Potential
Today 8:33 EDT
In a report published Friday, Deutsche Bank analyst Alethia Young initiated coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY ) with a Buy rating and $40.00 price target. In the report, Young noted,... Read More
category Deutsche Bank , Benzinga , ALNY , and 3 more.
from Latest Articles from Benzinga.com
Benzinga's Top Initiations
Today 7:54 EDT
Deutsche Bank initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ: ALNY ) with a “buy” rating. The target price for Alnylam Pharmaceuticals is set to $40. Alnylam's stock closed at $28.06... Read More
category Benzinga , CACC , Initiation , and 5 more.
from Latest Articles from Benzinga.com
Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
Today 7:17 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8367968 for the full story. Read More
from StreetInsider.com News Articles
Alnylam Pharmaceuticals: The Winning Streak Continues (ALNY)
May 22, 2013
from Comtex SmarTrend® News Briefs
Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference
May 21, 2013
from Business Wire News Releases
Investors Begin To Realize RNA’s Potential
May 21, 2013
from ACCESSWIRE
Alnylam Pharmaceuticals Has Returned 47.2% Since SmarTrend Recommendation (ALNY)
May 21, 2013
from Comtex SmarTrend® News Briefs
Post Earnings Update: Alnylam Pharmaceuticals Has Climbed 15.8% Higher in Past 2 Weeks (ALNY)
May 20, 2013
from Comtex SmarTrend® News Briefs
NASDAQ Gainers Watch List: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 18, 2013
New York, NY -- (SBWIRE) -- 05/18/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Alnylam Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
NASDAQ Gainers Watch List: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 17, 2013
Wilmington, DE -- (SBWIRE) -- 05/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Alnylam Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349864 for the full story. Read More
from StreetInsider.com News Articles
Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
May 17, 2013
from Business Wire News Releases
Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference
May 15, 2013
from Business Wire News Releases
Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference
May 08, 2013
from Business Wire News Releases
Alnylam Pharmaceuticals, Inc. (ALNY) Posts Q1 Loss of 15c/Share
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8308538 for the full story. Read More
from StreetInsider.com News Articles
Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results
May 06, 2013
from Business Wire News Releases
Trading Radar for 05/06: Scripps (SSP), Tyson Foods (TSN), First Solar (FSLR), Ruckus (RKUS), Vornado (VNO) Report
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8304336 for the full story. Read More
from StreetInsider.com News Articles
Alnylam Pharmaceuticals Has Returned 26.7% Since SmarTrend Recommendation (ALNY)
May 03, 2013
from Comtex SmarTrend® News Briefs
Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results
April 29, 2013
from Business Wire News Releases
(VPHM) ViroPharma Drug Candidate Pipeline Progresses
April 27, 2013
ViroPharma Incorporated (VPHM) recently announced results from a phase II study of its candidate... Visit StockBlogHub to view complete post. Read More
category Haemonetics Corporation , Biotechnology , Alnylam Pharmaceuticals Inc , and 9 more.
from Stock Blog Hub
Alnylam Pharmaceuticals Shares Up 27.6% Since SmarTrend's Buy Recommendation (ALNY)
April 26, 2013
from Comtex SmarTrend® News Briefs
Alnylam to Webcast Presentation at 12th Annual Needham Healthcare Conference
April 23, 2013
from Business Wire News Releases
Best Stocks: Biotech Still Holding Top Spots
April 22, 2013
Biotech remains at the top of his week's "10.0 report" with three new buy ratings. Read More
category ONXX , ALNY , ARNA , and 1 more.
from Minyanville Headlines
Healthways Inc. (NASDAQ:HWAY), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 19, 2013
New York, NY -- (SBWIRE) -- 04/19/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Healthways Inc. (NASDAQ:HWAY), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Alnylam... Read More
from SBWire - Latest Press Releases
Bullish Moving Average Cross by Alnylam Pharmaceuticals (ALNY)
April 19, 2013
from Comtex SmarTrend® News Briefs
Best Stocks: Four New Names, Four New Buys
April 15, 2013
Biotech names have leapt to the top of his week's "10.0 report" and offer 4 new buy ratings. Read More
category ALNY , ARNA , ISIS
from Minyanville Headlines
Ascletis and Roche to Develop Hepatitis C Treatment for China
April 15, 2013
Ascletis, a two-year-old China pharma startup, will collaborate with Roche to develop a Roche drug candidate for treatment of hepatitis C virus in China. Danoprevir is a protease inhibitor that has... Read More
from ChinaBio® Today
Uptrend Call Working As Alnylam Pharmaceuticals Stock Rises 22.8% (ALNY)
April 11, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Alnylam Pharmaceuticals Stock Rises 20.1% (ALNY)
April 04, 2013
from Comtex SmarTrend® News Briefs
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), and Affymax, Inc. (NASDAQ:AFFY) Added to Growing Stock Report's NASDAQ Decliners Watch List.
April 04, 2013
New York, NY -- (SBWIRE) -- 04/04/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Alnylam Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here